Monitoring Tumor Burden in Response to FOLFIRINOX Chemotherapy Via Profiling Circulating Cell-Free DNA in Pancreatic Cancer - Wei, Tao; Zhang, Qi; Li, Xiang; Su, Wei; Li, Guogang; Ma, Tao; Gao, Shunliang; Lou, Jianying; Que, Risheng; Zheng, Lei; Bai, Xueli; Liang, Tingbo (Molecular cancer therapeutics, 2019)
Keywords: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols - pharmacology; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Carcinoma, Pancreatic Ductal - drug therapy; Carcinoma, Pancreatic Ductal - genetics; Case-Control Studies; Circulating Tumor DNA - genetics; Female; Fluorouracil - pharmacology; Fluorouracil - therapeutic use; High-Throughput Nucleotide Sequencing - methods; Humans; Irinotecan - pharmacology; Irinotecan - therapeutic use; Leucovorin - pharmacology; Leucovorin - therapeutic use; Male; Middle Aged; Mutation; Oxaliplatin - pharmacology; Oxaliplatin - therapeutic use; Pancreatic Neoplasms - drug therapy; Pancreatic Neoplasms - genetics; Prospective Studies; Sequence Analysis, DNA; Treatment Outcome; Tumor Burden - drug effects